Form 10-Q · Quarterly report
NiSource 10-Q, filed Aug 5, 2026
- Filed
- CIK
- 0001111711
- Accession no.
- 0001111711-26-000088
Summary
NiSource reported in its quarterly report for the quarter ended June 30, 2026, that its disclosure controls and procedures were effective and that there were no material changes to its internal control over financial reporting, critical accounting estimates, or risk factors. CFO Shawn Anderson adopted a Rule 10b5-1 trading plan to sell up to 13,000 shares of common stock.
Key points
- NiSource's CEO and CFO concluded that its disclosure controls and procedures were effective as of the end of the quarter covered by the report.
- No changes in NiSource's internal control over financial reporting during the most recent quarter materially affected or were reasonably likely to materially affect those controls.
- CFO Shawn Anderson adopted a Rule 10b5-1 trading plan on May 14, 2026, to sell up to 13,000 shares of common stock, with a scheduled expiration date of November 30, 2026.
- NiSource reported no unregistered sales of equity securities, no defaults upon senior securities, and no material changes to its risk factors.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued) NiSource Inc. The financial status of our banking partners is periodically assessed through traditional credit ratings provided by major credit rating agencies. Other Information Critical Accounting Estimates A summary of our critical accounting estimates is included in the Company's Annual Report on Form 10-K for the year ended December 31, 2025. There were no material changes made as of June 30, 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.